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Hemodialysis (HD) is an intermittent procedure during which
large fluid and electrolyte shifts occur. We hypothesized that
sudden death occurrences in HD patients are related to the
timing of HD, and that they occur more frequently in the 12 h
period starting with dialysis and in the 12 h period at the end
of the dialysis-free weekend interval. In a retrospective study,
228 patient deaths were screened to determine if they met
the criteria for sudden death. Information was obtained from
clinic charts, dialysis center records, and interview of
witnesses of the death event. There were 80 HD patients who
met the criteria for sudden death. A bimodal distribution of
death occurrences was present, with a 1.7-fold increased
death risk occurring in the 12 h period starting with the
dialysis procedure and a threefold increased risk of death in
the 12 h before HD at the end of the weekend interval
(P¼ 0.011). Patients with sudden death had a high
prevalence of congestive heart failure and coronary artery
disease. Only 40% of patients experiencing sudden death
were receiving beta-blockers, and the prior monthly serum
potassium value was less than 4 mEq/l in 25%. Sudden death
is temporally related to the HD procedure. Every other day
HD could be beneficial in preventing sudden death. Careful
attention to the usage of beta-blockers and to the
maintenance of normal serum potassium values is indicated
in HD patients at risk for sudden death.
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Cardiovascular disease is accelerated in end-stage kidney
disease patients and is responsible for much of the increased
mortality observed in hemodialysis (HD) patients. The
incidence of cardiac arrest or cardiac arrhythmia was 62/
1000 patient years at risk for all US dialysis patients between
1999 and 2001, accounting for 26% of all deaths. The
incidence was 93.7/1000 patient years at risk for dialysis
patients greater than 65 years of age.1 This incidence is almost
twice than that found in the year following myocardial
infarction in a group of patients from the general population
with coronary artery disease (CAD) (approximately 51
deaths/1000 patient years).2 The high rate of sudden death
in the dialysis population may not only be related to the high
prevalence of underlying cardiac disease but also the stress of
the HD procedure itself. The purpose of the present study
was to determine the timing and characteristics of sudden
death in a population of dialysis patients. A previous study
showed an increased rate of sudden death on Mondays for
Monday, Wednesday, and Friday HD patients and Tuesdays
for Tuesday, Thursday, and Saturday HD patients.3 However,
this study was unable to determine the exact timing of
sudden death (i.e. if deaths occurred in the hours before or
after dialysis). In addition, previous studies have involved
large databases and not been able to examine each individual
death and apply a strict definition of sudden death. The
rationale for this study was that detailed analysis of sudden
death events and patients sustaining them would provide a
better characterization of this common event and provide
insights into potential methods of prevention.
HD is typically performed on Monday, Wednesday, and
Friday, or Tuesday, Thursday, and Saturday for the vast
majority of dialysis patients. This timing results in two 48 h
and one 72 h interval between the start of dialysis treatments
(see Figure 1). We hypothesized that sudden death events
were more likely to occur in the 12 h interval beginning with
the start of dialysis and in the last 12 h interval (occurring
60–72 h after dialysis) that occurs once a week at the end of
the weekend dialysis-free interval as compared to the 12–60 h
interval.
RESULTS
Of 228 deaths reviewed, 88 (39%) met the criteria for sudden
death. On the End-Stage Renal Disease Death Notification
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Form (Form HCFA 2746-U3), the patient’s primary ne-
phrologist classified 59 (67%) of these deaths as cardiac
arrest, cause unknown, six as acute myocardial infarction,
four atherosclerotic heart disease, three cardiomyopathy, two
pulmonary edema, two ‘other’, one valvular heart disease, and
11 unknown. Of the 140 deaths that did not meet the criteria
for sudden death, 13 (9.3%) were classified as cardiac arrest
cause unknown. Eight of the patients who suffered from
sudden death were patients undergoing peritoneal dialysis
and were excluded from the rest of the analysis. Of the 80
sudden deaths, 51 (64%) were witnessed. There was a p2 h
interval for 11 patients (14%), 2–5 h for eight patients (10%),
and 8–12 h for eight patients (10%). For one patient, the hour
of death could not be determined accurately. For one patient,
the timing of the last dialysis could not be determined.
Figure 2 shows the ratio of observed to expected death
proportions for each 12 h time interval, assuming an equal
temporal distribution of death. The observed to expected
death rates overall were significantly different than expected
(P¼ 0.0008). There were 28.5 deaths in the first 12 h period
compared to the expected 16.6 deaths (1.71 ratio observed to
expected, P¼ 0.036). Of these deaths, 12/28.5 (42.1%)
occurred during the dialysis procedure. For the rest of the
interval, there were 16.5 deaths vs the expected 11.1 deaths
(1.49 ratio observed to expected, P¼ 0.10). After the first
12 h period, the death occurrences decreased dramatically
and then began to increase at the 48–60 h interval. This
interval occurs on Sunday morning for Monday, Wednesday,
and Friday HD patients, and represents the time the patient
would return for dialysis if dialysis was performed every other
day and there was no weekend interval. In the 60–72 h time
period, there were three times as many observed deaths as
expected (16.5 vs 5.5 expected, P¼ 0.011).
Of the 29 deaths occurring in the 12 h period beginning
with the dialysis treatment (0–12 h interval), nine (31%)
occurred following the dialysis treatment after the weekend
interval – that is, on Monday or Tuesday vs the 33% expected
(P¼NS).
Table 1 shows the characteristics of patients who suffered
sudden death. A large proportion of the patients suffered
from CAD, other vascular disease, congestive heart failure
(CHF), or diabetes mellitus. CHF or CAD was present in 57
of 80 patients (71%).
Echocardiograms were performed in 69 individuals who
ultimately suffered sudden death. The mean time interval
from the time of the echocardiogram until death was 9.8712
months. Results from these echocardiograms and prior electro-
cardiograms are shown in Table 1. Electrocardiographic
findings revealed left bundle branch block in 9% of patients,
atrial fibrillation/flutter in 9.0%, and a paced rhythm in
3.9%. A prolonged corrected QT interval (40.44 s) was
present in 53.5% of patients.
Nineteen of the 77 patients (24.7%) with prior monthly
laboratory studies had a serum potassium value less than
4 mEq/l. In the previous month, nine (47%) of these patients
had a serum potassium value less than 4 mEq/l. In all, 27% of
patients had a serum albumin o3 g/dl in the previous
month, 50% had a hemoglobin o11 g/dl, and the serum
phosphorus was greater than 6.5 mg/dl in 36% patients.
Only 32 of 80 (40.0%) patients were receiving a beta-
blocker. Only 9/32 (28.1%) patients with a left ventricular
ejection fraction o50% were receiving beta-blockers. Of 45
patients with CAD, 19 (42.2%) were receiving a beta-blocker.
Of 24 patients receiving dihydropyridine calcium channel
blockers, 15 (63%) were receiving beta-blockers. Character-
istics of the final HD treatment are presented in Table 2.
Characteristics of individuals who died in the 0–12 h
interval are compared to those who died in the 12–60 h
period and the 60–72 h period in Table 3. There was a trend
for patients who died in the 0–12 h interval to have an
increased incidence of CHF, CAD, and stroke. In contrast, the
individuals who died in the 60–72 h interval had a lower
incidence of these conditions, although not statistically
significant. The serum potassium of individuals in the
60–72 h interval tended to be higher than that of individuals
in the 0–12 h interval. Patients who died in the 60–72 h were
more likely to be on beta-blockers (58.8%) than individuals























24 36 48 0 12 24 36 48 60 72
00 12 24 36 48









0−12 12−24 24−36 36−48 48−60 60−72

















Figure 2 | Ratio of actual to expected number of occurrences of
sudden death for each 12 h interval beginning with the start
of HD.
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DISCUSSION
This is the first study in the HD population examining
sudden death in which events were classified according to a
standard definition and in which complete characterization
of each sudden death event was performed. The present study
identifies the HD procedure as a major stressor leading to
increased sudden death in the 12 h period starting with the
dialysis session. The last day of the dialysis-free weekend
interval is also associated with a markedly increased rate of
sudden death.
The stress resulting in sudden death in the first 12 h period
likely derives from the fact that in a very short 4 h period,
toxins and fluids that accumulate over 44 or 68 h must be
removed. This greatly contrasts with the smooth, continuous
clearance provided by the normal kidneys. Unlike the stress
from snow shoveling or many other activities known to
increase sudden death risk,4 dialysis occurs repeatedly at
regular intervals and is usually not stopped when the patient
develops nonspecific symptoms that might precede death.
There was a 1.7 fold increased risk of sudden death events
in the 12 h period beginning with the dialysis treatment.
Sudden death events were increased both during the dialysis
procedure itself and after treatment. Previous studies have
noted a number of factors occurring with HD that could lead
to cardiac arrhythmias. Potassium fluxes have been associated
with an increased incidence of ventricular ectopy,5 an
increased QT interval, and an increased QT dispersion
during the HD interval6–8 – all predictors of sudden death.
Patients who died in the first 12 h interval had a lower mean
serum potassium level in the prior monthly labs than those
dying in the 60–72 h interval, although this did not reach
statistical significance – possibly owing to the small sample
size. Characterization of sudden death occurring during
dialysis has been studied previously. Karnik et al.9 noted that
treatment with a 0 mEq/l potassium dialysate was associated
with an increased risk of death; a zero potassium dialysate
was not available in the outpatient dialysis units in this study,
and all patients were maintained on a standard 2.0 mEq/l
potassium dialysate.
Ifudu et al.10 have noted a mean pre-dialysis serum
potassium of 5.0470.69 mEq/l (range 3.3–7.4 mEq/l) in a
study of 269 stable HD patients compared to a mean serum
potassium value of 4.5070.84 mEq/l in our study. Extremes
of serum potassium values are noted in both studies, and
both hyper- and hypokalemia are well-known risk factors for
sudden cardiac death.11
Increased sympathetic activity occurs with HD,12 and
increased sympathetic tone has been associated with
mortality and cardiovascular events in the dialysis popula-
tion.13 Patients who suffered sudden death in the 0–12 h
interval were much less likely to be on beta-blockers than
Table 2 | Characteristics of the dialysis treatment preceding
sudden death
Characteristic Mean7s.d. or n (%)
Pre-systolic blood pressure (mm Hg) 140.0726.2
o100 5 (6.6%)
100 to o160 60 (80.2%)
X160 11 (13.2%)
Pre-dialysis mean diastolic pressure (mm Hg) 72.8715.0
Pre-dialysis mean arterial pressure (mm Hg) 95.2717.2




Post-dialysis diastolic blood pressure (mm Hg) 66.9715.6
Post-dialysis mean arterial pressure (mm Hg) 86.6717.4
Mean weight removal (lb) 4.5272.9
Mean weight removal (%) 2.9771.88
Table 1 | Patient characteristics




Vintage (years on dialysis before event) 3.5373.6
Hypertension 74 (92.5%)
History of seizures 8 (10.3%)
Significant non-compliance 17 (21.3%)
Tobacco usage 41 (51.3%)
Diabetes mellitus 46 (57.5%)
Coronary artery disease 45 (56.3%)




35 to o50% 15 (21.7%)
50 to o60% 26 (37.7%)
460% 11 (15.9%)
Segmental wall motion abnormalities 33 (47.8%)
Electrocardiographic findings
Rate (b.p.m.) 84.6717.9
QT corrected (ms) 450740
QT dispersion (ms) 60730
QTc dispersion (ms) 90750
QTc dispersion (%)
0 to o40 ms 5 (7.0%)
40 to o 90 ms 34 (47.9%)
X90 32 (45.1%)
Serum potassium (mEq/l) 4.5070.84
o3.5 mEq/l 10 (13.0%)
3.5 to o4.0 mEq/l 9 (11.7%)
4.0 to o5.0 mEq/l 39 (50.6%)
5.0 to o6.0 mEq/l 14 (18.2%)
X6.0 mEq/l 5 (6.5%)
Serum calcium (mg/dl, adjusted) 9.471.2a
Serum phosphorus (mg/dl)b 5.9772.7
Serum albumin (g/dl)c 3.570.50
Hemoglobin (g/dl)c 10.971.6
b.p.m., beats per minute; LVEF, left ventricular ejection fraction.
aTo convert to international units (mmol/l), multiply by 0.02495.
bTo convert to international units (mmol/l), multiply by 0.323.
cTo convert to international units (g/l), multiply by 10.
2270 Kidney International (2006) 69, 2268–2273
o r i g i n a l a r t i c l e AJ Bleyer et al.: Sudden death in dialysis patients
individuals who suffered sudden death in the 60–72 h
interval. There are a number of potential reasons for this
that will have to be addressed in further studies. Increases in
sympathetic activity have been associated with the dialysis
treatment,12,14 and increased sympathetic activity is a well-
known risk factor for sudden death.15 Beta-blockers are
believed to prevent ventricular arrythmias in the setting of
increased adrenergic stimulation.16 Alternatively, beta-block-
ers could be deleterious to patients in the 60–72 h interval.
Beta-blockers may lead to increased hyperkalemia,17 which is
more likely to be a problem at the end of the dialysis interval.
One study found that predialysis serum potassium was
increased by 0.7 mEq/l in HD patients treated for 10 days
with propranolol, but was unchanged with treatment with
atenolol.18,19 A third explanation is that there is a treatment
indication bias; patients who died in the 60–72 h interval were
in general healthier and may have tolerated beta-blockers
better and therefore been prescribed them more frequently.
The high prevalence of cardiomyopathy and CAD in our
study population provides the perfect setting for arrhythmias
to occur. In addition, many patients suffered from an
increased QT interval. There was a trend that patients dying
in the first time interval to more likely suffer from CHF,
CAD, and stroke than those who died in the 60–72 h interval,
implying that this interval is more stressful to these
individuals than healthier patients.
Once patients survived the acute peri-dialysis period, there
was a dramatic decline in the sudden death rate. The sudden
death rate then began to rise at the 48–60 h interval. Patients
would normally return to dialysis at 48 h in the absence of the
weekend interval. In the last 12 h of the weekend interval,
sudden death was three times more likely to occur. Increasing
volume overload, worsening hypertension, and hyperkalemia
all occur before dialysis, and both hypertension and
hyperkalemia have been associated with an increased
incidence of sudden death.20,21 Although the weekend
interval is highly valued by patients and staff alike, it is
associated with a much higher risk of cardiac mortality. The
fact that the weekend in general is a time of increased fluid
and electrolyte intake likely aggravates this problem. In a
prior study, we noted an increased cardiac death rate on
Monday for Monday, Wednesday, and Friday HD patients,
and on Tuesday for Tuesday, Thursday, and Saturday dialysis
patients, but the timing related to the HD session could not
be determined.22 This investigation suggests that the high
death rates on Monday and Tuesday are owing to the
increased occurrences of death in the 60–72 h interval
preceding dialysis; the proportion of deaths occurring in
the 12 h interval starting with dialysis were similar, no matter
which dialysis treatment of the week was examined.
A weakness of the study was the collection of only a
sample of the deaths occurring in the dialysis centers studied.
This did not allow for the calculation of incident rates of
sudden death. The sample collected was done so without
apparent bias, and the clerical personnel collecting the death
notification forms were not aware of the purpose of the
study.
Sudden death is not the result of dialysis-induced stress
producing cardiac arrest in relatively healthy individuals, but
rather the stress of dialysis leading to death in those with
underlying cardiac disease. Patients who suffered sudden
death had a very high prevalence of CHF (55.7%),
cardiomyopathy (mean left ventricular ejection fraction
45.7716.7%), and CAD (55.7%). Diabetes mellitus, CHF,
peripheral vascular disease, or CAD was present in 87.5% of
cases. These figures are likely to be an underestimate, as
undetected CAD or cardiomyopathy may have been present
before death. In a prior study of the dialysis centers involved
in this study,23 the prevalence of CHF for the entire dialysis
population was 28%, and the prevalence of CAD was 23%. In
the United States Renal Data System Dialysis Morbidity and
Mortality Wave II Study,24 a random sampling of dialysis
centers in the United States, the prevalence of CHF was
40.8%, and the prevalence of CAD was 37.6%. This study
shows that the HD patients suffering from sudden death have
underlying cardiac disease. Sudden death did not occur in
patients who had normal hearts and perhaps developed
hypokalemia or other metabolic abnormalities as a result of
dialysis.
The results of this study raise the possibility that
additional therapies could be immediately employed in an
attempt to reduce the high rates of sudden death observed in
Table 3 | Characteristics of individuals suffering sudden death according to time interval
Characteristica 0–12 h interval 12–60 h interval 60–72 h interval P-valueb
Left ventricular ejection fraction (%) 45.4716.7 46.6718.0 50.0716.6 0.55
Congestive heart failure (%) 62.1 56.3 35.3 0.20
Coronary artery disease (%) 55.2 62.5 41.2 0.36
Left ventricular hypertrophy (%) 25.0 40.6 50.0 0.21
Peripheral vascular disease (%) 44.8 46.9 17.7 0.11
Stroke (%) 27.6 28.1 5.6 0.16
Diabetes mellitus (%) 62.1 62.5 35.3 0.14
Frequent non-compliance (%) 17.3 21.9 23.5 0.85
Beta-blocker usage (%) 31.0 37.5 58.8 0.01
Weight gain between treatments 4.572.7 4.673.2 4.472.6 0.99
Serum potassium (mEq/l) in previous month 4.4770.73 4.3070.80 4.8671.0 0.18
aFor discrete variables, values represent percentage with described condition; for continues variables, values represent mean+s.d.
bA w2 test was used for the comparison of discrete variables, and analysis of variance testing was performed for continuous variables.
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HD patients. Only 40% of patients were taking beta-blockers
at the time of death, despite the presence of hypertension in
the majority of dialysis patients. Many hypertensive patients
were receiving dihydropyridine calcium channel blockers.
Other studies have also revealed a decreased rate of beta-
blocker usage in dialysis patients.25 Usage of beta-blockers in
patients with CAD or CHF have been associated with a
marked decrease in sudden death.26 A randomized trial of
carvedilol recently showed a survival advantage in HD
patients with cardiomyopathy.27 A prospective observational
study also suggested a potential benefit of beta-blockers in
diabetic dialysis patients.28
A recent investigation documented a protective effect of
prophylactic defibrillator implantation in patients with non-
ischemic dilated cardiomyopathy and a left ventricular
ejection fraction less than 35%. One-fourth of the patients
who suffered sudden death in this study had an ejection
fraction less than 35% and may have benefited from
defibrillator implantation.
Another potential therapeutic option is the more frequent
adjustment of the dialysis bath in dialysis patients. In all,
24.7% of the patients had a serum potassium value less than
4 mEq/l in the month leading up to sudden death and did not
undergo changes in their dialysate bath, with all patients
being dialyzed against a standard 2.0 mEq/l potassium bath.
Increasing the dialysate potassium would decrease ventricular
ectopy and increase the patient’s baseline serum potassium
levels, which would also decrease the QT interval and QT
dispersion during HD – two factors associated with an
increased sudden death rate.
A high proportion of deaths occurred during the 4 h
dialysis interval, and recent National Kidney Foundation
guidelines advocate the presence of defibrillators in all
dialysis centers. Defibrillators were present throughout the
course of the study in the centers that participated.
Of note, in a recent investigation by Herzog et al.,29 CHF,
coupled with hypoalbuminemia and anemia, were associated
with a very high annual mortality. A low mean hemoglobin
level and low albumin level were noted in our patient
population, and correction of these values could potentially
improve survival.
Future prospective clinical trials directed at preventing
sudden death in dialysis patients should be performed. A
recent trial of atorvastatin in HD patients with type II
diabetes30 demonstrated that therapeutic options proven
beneficial in the general population may not have similar
effects in HD patients.
For many years, nephrologists have concentrated research
efforts on perfecting the dialysis technique. However, recent
trials have not shown an improvement in patient survival in
patients receiving increased dose of dialysis.31,32 The present
study suggests that an increased frequency of dialysis may be
beneficial and could potentially prevent sudden death.
Whereas daily dialysis might be beneficial, simply increasing
treatments to four times per week and avoiding a 3-day
dialysis-free interval might have a substantial effect.
It is important to note that despite suffering from
cardiovascular disease and renal failure, many of the patients
were leading productive lives at the time of their death. Their
unexpected death actually provided the motivation to
perform this study. Prevention of death in these patients
would increase duration of life in many individuals who still
have a high quality of life.
MATERIALS AND METHODS
This study was approved by the Wake Forest University School of
Medicine Institutional Review Board. A sample of Form HCFA
2746-U3 was obtained from five dialysis centers in the southeastern
United States between 1995 and 2003. Owing to changes in the
clerical personnel at the dialysis centers over the time course of the
study, all death notifications were not forwarded to the investigators.
The lapses in collection appeared random in nature. Health
Insurance Portability and Accountability Act of 1996 concerns of
the participating dialysis centers precluded the retrospective
ascertainment of all deaths for these intervals. The participating
centers refused to provide information in retrospect on the missing
individuals, as it was felt that providing identifying information
about these patients would be a breach of confidentiality, despite
approval by the Institutional Review Board of Wake Forest
University School of Medicine. The dialysis centers participating
in the study had survival rates that are similar to national HD
patient survival rates. The centers were composed of approximately
50% African-American patients over the time period of the study.
End-Stage Renal Disease Death Notification Forms (Form HCFA
2746-U3) were reviewed at approximately annual intervals during
the study. Sudden death was defined as unexpected, ans non-
traumatic death occurring within 1 h of the onset of symptoms.
Patient charts were reviewed, and patients who had other
precipitating causes of death (e.g. sepsis, withdrawal from dialysis)
were not included. Patients who suffered sudden death after the 72 h
interval (owing to missed treatment or other reasons) were not
included. Whether patients met sudden death criteria were
adjudicated by two of the authors (AJ Bleyer and J Hartman).
Deaths during sleep and un-witnessed deaths occurring at home
were considered as sudden deaths. Information regarding the
sudden death event was obtained from chart review and from
interviews with witnesses to the death event. Interviews with
witnesses of death events have been helpful in determining sudden
death in the investigation of sudden death by Hinkle and Thaler,33
and also in the Framingham Heart Study.34 If the death was not
witnessed, the time the patient was last seen alive and the time the
patient was found dead were recorded.
Demographic data and comorbid conditions were obtained by
chart review. CHF was defined as admission for volume overload or
a clinical diagnosis of CHF found in the chart. CAD was defined as a
history of myocardial infarction, angina, positive stress test, or
coronary artery bypass surgery. Peripheral vascular disease was
defined as a history of amputation, lower extremity vascular bypass
surgery, or intermittent claudication. Cerebrovascular disease was
defined as a history of stroke, transient ischemic attack, or carotid
endarterectomy. Non-compliance was defined as a history of missed
treatments, markedly excessive fluid gains, or marked, willful non-
compliance with medications. Data were obtained from the patient’s
most recent echocardiogram and electrocardiogram. The QT
interval was calculated as the mean QT interval obtained from 12
different leads on the electrocardiogram using Bazett’s formula
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(QTc). The serum potassium and calcium values were obtained
from the patient’s most recent monthly laboratory values, and from
the month prior. The serum calcium was adjusted for serum
albumin as described previously.35
The timing of sudden death was determined as the time from the
start of dialysis until the time of death. If the exact time of death was
not known, the probability of death was evenly distributed from the
time the patient was last seen alive to the time the patient was found
dead. For instance, if the patient was last seen alive 6 h after dialysis
and was found dead 8 h after dialysis, a value of 0.5 was given for the
hour between 6 and 7 h, and 0.5 for the hour between 7 and 8 h. We
hypothesized that a higher proportion of sudden deaths would
occur in the 12 h interval beginning with the start of dialysis and in
the 12 h interval occurring from 60 to 72 h after the start of dialysis.
This latter interval occurs once during the week – occurring at the
end of the weekend interval. The relative risk is calculated as the
proportion of observed deaths in the 12 h interval vs the expected
number of deaths, assuming that the occurrence of death would be
evenly distributed over time. As Figure 1 demonstrates, the 48–60 h
and the 60–72 h interval occur only one time during the week, as
compared to three times per week for each of the other time
intervals. Therefore, one would expect one-third as many deaths in
these two later intervals. A w2 test was performed to determine
significance.
Statistical analysis was performed by Gregory Russell, PhD,
Anthony Bleyer, MD, and Joel Hartmann, MD. Descriptive statistics,
including means, s.d.’s, and ranges for continuous measures and
frequencies and proportions for categorical data, were calculated. w2
tests were used to test for differences between observed and expected
frequencies in day and timing of deaths of patients. For other
categorical measures, w2 tests were used to test for association
between outcome measures and day/time of death.
ACKNOWLEDGMENTS
We thank Dr William Little for his review of this paper.
REFERENCES
1. Table H.16 Death Rates by Primary Cause of Death: Dialysis Patients,
Unadjusted, in USRDS 2003 Annual Data Report: Atlas of End-Stage Renal
Disease in the United States, edited by U.S. Renal Data System, Bethesda,
MD, 2003, p 484.
2. Kannel WB, Schatzkin A. Sudden death: lessons from subsets in
population studies. J Am Coll Cardiol 1985; 5: 141B–149B.
3. Bleyer AJ, Russell GB, Satko SG. Sudden and cardiac death rates in
hemodialysis patients. Kidney Int 1999; 55: 1553–1559.
4. Franklin B, Bonzheim K, Gordon S, Timmis G. Snow shoveling: a trigger for
acute myocardial infarction and sudden coronary death. Am J Cardiol
2004; 77: 855–858.
5. Morrison G, Michelson EL, Brown S, Morganroth J. Mechanism and
prevention of cardiac arrhythmias in chronic hemodialysis patients.
Kidney Int 1980; 17: 811–819.
6. Lorincz I, Matyus J, Zilahi Z et al. QT dispersion in patients with end-stage
renal failure and during hemodialysis. J Am Soc Nephrol 1999; 10:
1297–1302.
7. Cupisti A, Galetta F, Caprioli R et al. Potassium removal increases the QTc
Interval dispersion during hemodialysis. Nephron 1999; 82: 122–126.
8. Morris S, Galiatsou E, Stewart G et al. QT dispersion before and after
hemodialysis. J Am Soc Nephrol 1999; 10: 160–163.
9. Karnik JA, Young BS, Lew NL et al. Cardiac arrest and sudden death in
dialysis units. Kidney Int 2001; 60: 350–357.
10. Ifudu O, Reydel K, Vlacich V et al. Dietary potassium is not the sole
determinant of serum potassium concentration in hemodialysis patients.
Dial Transplant 2004; 33: 684–693.
11. Bleyer AJ. Sudden death in dialysis patients. Cardiac Electro-Physiol Rev
2001; 5: 419–421.
12. Daugirdas JT. Pathophysiology of dialysis hypotension: an update.
Am J Kidney Dis 2001; 38: S11–S17.
13. Zoccali C, Mallamaci F, Parlongo S et al. Plasma norepinephrine predicts
survival and incident cardiovascular events in patients with end-stage
renal disease. Circulation 2004; 105: 1354–1359.
14. Converse RL, Jacobsen TN, Jost CMT et al. Paradoxical withdrawal of
reflex vasoconstriction as a cause of hemodialysis-induced hypotension.
J Clin Invest 1992; 90: 1657–1665.
15. Muller J, Kaufmann P, Luepker R et al. Mechanisms precipitating acute
cardiac arrest: review and recommendations of an NHLBI workshop.
Circulation 1997; 96: 3233–3239.
16. Dorian P. Antiarrhythmic actions of beta-blockers: potential mechanisms.
J Cardiovasc Pharmacol Ther 2005; 10: S15–S22.
17. Ponce SP, Jennings AE, Madias NE, Harrington JT. Drug induced
hyperkalemia. Medicine 1985; 64: 357–370.
18. Arrizabalaga P, Montolium J, Martinez VA et al. Increase in serum
potassium caused by beta-2 adrenergic blockage in terminal renal failure:
absence of mediation by insulin or aldosterone. Proc Eur Dial Transplant
Assoc 1983; 20: 572–576.
19. Allon M. Treatment and prevention of hyperkalemia in end-stage renal
disease. Kidney Int 1993; 43: 1197–1209.
20. Zehender M, Faber T, Koscheck U et al. Ventricular tachyarrhythmias,
myocardial ischemia, and sudden cardiac death in patients with
hypertensive heart disease. Clin Cardiol 1995; 18: 377–383.
21. Johnston R, de Bono D, Nyman C. Preventable sudden death in
patients receiving angiotensin converting enzyme inhibitors and
loop/potassium sparing diuretic combinations. Int J Cardiol 1992; 34:
213–215.
22. Bleyer AJ, Russell GB, Satko SG. Sudden and cardiac death rates in
hemodialysis patients. Kidney Int 1999; 55: 1553–1559.
23. Bleyer AJ, Tell GS, Evans GW et al. Survival of patients undergoing renal
replacement therapy in one center with special emphasis on racial
differences. Am J Kidney Dis 1996; 28: 72–81.
24. Abbott KC, Glanton CW, Trespalacios FC et al. Body mass index, dialysis
modality, and survival: analysis of the United States Renal Data System
Dialysis Morbidity and Mortality Wave II Study. Kidney Int 2004; 65:
597–605.
25. Berger AK, Duval S, Krumholz HM. Aspirin, beta-blocker, and
angiotensin-converting enzyme inhibitor therapy in patients with
end-stage renal disease and an acute myocardial infarction. J Am Coll
Cardiol 2003; 42: 201–208.
26. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart
failure. Lancet 1999; 353: 2001–2007.
27. Cice G, Ferrara L, Di Benedetto A et al. Dilated cardiomyopathy in dialysis
patients – beneficial efects of carvedilol: a double-blind, placebo-
controlled trial. J Am Coll Cardiol 2001; 37: 407–411.
28. Koch M, Thomas B, Tschope W, Ritz E. Survival and predictors of death in
dialysed diabetic patients in Europe. Diabetologia 1993; 36: 1113–1117.
29. Herzog CA, Muster HA, Li S, Collins AJ. Impact of congestive heart failure,
chronic kidney disease, and anemia on survival in the Medicare
population. J Card Fail 2004; 10: 467–472.
30. Wanner C, Krane V, Marz W et al. Atorvastatin in patients with type 2
diabetes mellitus undergoing hemodialysis. N Engl J Med 2005; 353:
238–248.
31. Cheung AK, Levin NW, Agodoa L et al. Effects of high-flux hemodialysis
on clinical outcomes: results of the HEMO study. J Am Soc Nephrol 2003;
14: 3251–3263.
32. Panigua R, Amato D, Vonesh E et al. Mexican Nephrology Collaborative
Study Group. Effects of increased peritoneal clearances on mortality rates
in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled
trial. J Am Soc Nephrol 2002; 13: 1307–1320.
33. Hinkle LE, Thaler HT. Clinical classification of cardiac deaths. Circulation
1982; 65: 457–464.
34. Willich SN, Levy D, Rocco MB et al. Circadian variation in the incidence of
sudden cardiac death in the Framingham Heart Study population. Am J
Cardiol 1987; 60: 801–806.
35. Popovtzer MM, Knochel JP, Kumar R. Disorders of calcium, phosphorus,
vitamin D, and parathyroid hormone activity, chapter 6. In: Schrier RW
(ed). Renal and Electrolyte Disorders, 5th edn. Lippincott-Raven:
Philadelphia, PA, 2004, pp 241–319.
Kidney International (2006) 69, 2268–2273 2273
AJ Bleyer et al.: Sudden death in dialysis patients o r i g i n a l a r t i c l e
